DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oxyir (Oxycodone Hydrochloride) - Indications and Dosage

 
 



INDICATIONS AND USAGE

For the relief of moderate to moderately severe pain.

DOSAGE AND ADMINISTRATION

SPECIAL PRECAUTIONS REGARDING OXYFAST ORAL CONCENTRATE 20 MG/1 ML SOLUTION

OXYFAST 20 mg/1 mL solution is a highly concentrated solution. Care should be taken in the prescription and dispensing of this solution strength. Patients should be instructed against use by individuals other than the patient, as inappropriate use may cause acute overdosage.

Dosage should be adjusted to the severity of the pain and the response of the patient. It may occasionally be necessary to exceed the usual dosage recommended below in cases of more severe pain or in those patients who have become tolerant to the analgesic effects of opioids. This drug is given orally. The usual adult dosage is 5 mg every 6 hours as needed for pain.

NURSE/PATIENT INSTRUCTIONS

Fill dropper to the level of the prescribed dose (1.0 mL=20 mg; 0.75 mL=15 mg; 0.5 mL=10 mg and 0.25 mL=5 mg). For ease of administration, add dose to approximately 30 mL (1 Fl Oz) or more of juice or other liquid. May also be added to applesauce, pudding or other semi-solid foods. The drug-food mixture should be used immediately and not stored for future use.

HOW SUPPLIED

OxyIR® (oxycodone hydrochloride) Immediate-Release Oral Capsules:

5 mg capsules, Cap: Beige Imprinted with O-IR; Body: Orange Imprinted with PF 5mg

NDC 59011-201-10: Opaque plastic bottle containing 100 capsules

OXYFAST (oxycodone hydrochloride) Oral CONCENTRATE Solution

20 mg per 1 mL clear yellow liquid

NDC 59011-225-20: Plastic bottle with child-resistant dropper in 30 mL size.

Discard opened bottle of oral solution after 90 days.

Store OXYFAST Oral CONCENTRATE solutions and OxyIR (oxycodone hydrochloride) capsules at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F).

CAUTION

DEA Order Form Required.

Printed in USA

Purdue Pharma L.P., Stamford, CT 06901-3431

©1996, 2003, Purdue Pharma L.P.

August 4, 2003

OT00623A          061430-0C-001

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012